A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment)

ConditionsFood Allergies Peanut Allergies Egg Allergy Milk Allergy

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorMurdoch Childrens Research Institute

About this trial

The goal of this observational study is to learn about the long-term outcomes of children and young people who underwent an 18-month course of oral immunotherapy (OIT) treatment for peanut, egg or milk allergy. It aims to:

• Compare long-term changes in health-related quality of life (HRQL) at 5-15 years after stopping OIT in participants who achieved remission and those who did not.

Participants will attend a single follow-up visit for:

* A blood test * Skin prick test (SPT) * Allergy questionnaires

Eligibility criteria

Qualifiers

Previous participant of PEAT, PrEMO, PPOIT-001 or PPOIT-002 parent study

Received at least one dose of OIT treatment in the parent study

Written informed consent from participant and/or parent/guardian (if below 18 years of age)

Disqualifiers

None

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Murdoch Childrens Research Institute

Lead sponsor

Source ClinicalTrials.gov